BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021

Rhea-AI Summary

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) will announce its second quarter 2021 financial results on August 4, 2021, prior to market opening. A conference call will follow at 8:30 AM ET to discuss these results and provide an update on business operations. The company focuses on specialty pharmaceuticals for chronic conditions, using its proprietary BioErodible MucoAdhesive (BEMA®) technology. BDSI aims to address unmet medical needs related to chronic pain and opioid-induced constipation.

RALEIGH, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its second quarter 2021 financial results before the open of the U.S. financial markets on Wednesday, August 4, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date:	Wednesday, August 4, 2021
Time:	8:30 AM Eastern Time
Domestic:	877-407-0789
International:	201-689-8562
Conference ID:	13720500
Webcast:	http://public.viavid.com/index.php?id=145242

About BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA^®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

© 2021 BioDelivery Sciences International, Inc. All rights reserved.

Contact:
Bob Yedid
LifeSci Advisors
646-597-6989
Bob@LifeSciAdvisors.com

FAQ

When will BDSI report its second quarter 2021 financial results?

BDSI will report its second quarter 2021 financial results on August 4, 2021.

What time is the BDSI conference call for Q2 2021 results?

The conference call will take place at 8:30 AM Eastern Time on August 4, 2021.

What is BDSI's focus in the pharmaceutical market?

BDSI focuses on developing products for patients with chronic conditions, including chronic pain and opioid-induced constipation.

How can I access the BDSI webcast for the Q2 2021 results?

The BDSI Q2 2021 results webcast can be accessed through this link.

What technology does BDSI utilize in its products?

BDSI uses its proprietary BioErodible MucoAdhesive (BEMA®) technology in its products.